Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 2 7Phase 1/2 4Phase 1 4Phase 3 3Phase 2/3 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Transurethral Resection of Bladder × Clear all
NCT07000084 2026-04-07

GAIN-BCG

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
330 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07067749 2025-07-24

TEMPO-MIBC

University of Rome Tor Vergata

Phase 3 Recruiting
92 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT01900327 2018-05-11

NEOPA

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Terminated
32 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡